Company
Antiva Biosciences
| Industry | biopharmaceutical company developing topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Antiva Biosciences | Series E Equity Financing | 2023-04-27 |